Detalhe da pesquisa
1.
CD14+ HLA-DR-/low MDSCs are elevated in the periphery of early-stage breast cancer patients and suppress autologous T cell proliferation.
Breast Cancer Res Treat
; 168(2): 401-411, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29230664
2.
Immune profiles of elderly breast cancer patients are altered by chemotherapy and relate to clinical frailty.
Breast Cancer Res
; 19(1): 20, 2017 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-28241844
3.
Presence of circulating Her2-reactive CD8 + T-cells is associated with lower frequencies of myeloid-derived suppressor cells and regulatory T cells, and better survival in older breast cancer patients.
Breast Cancer Res
; 17: 34, 2015 Mar 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25849846
4.
Risk-associated alterations in marrow T cells in pediatric leukemia.
JCI Insight
; 5(16)2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692727
5.
Differential effects of PD-L1 versus PD-1 blockade on myeloid inflammation in human cancer.
JCI Insight
; 5(12)2020 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32427579
6.
Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy.
JCI Insight
; 52019 04 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31013254
7.
Low levels of intra-tumoural T cells in breast cancer identify clinically frail patients with shorter disease-specific survival.
J Geriatr Oncol
; 9(6): 606-612, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29685380
8.
Early B cell changes predict autoimmunity following combination immune checkpoint blockade.
J Clin Invest
; 128(2): 715-720, 2018 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29309048
9.
The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.
Oncotarget
; 7(21): 29977-88, 2016 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27102154
10.
Prognostic impact of circulating Her-2-reactive T-cells producing pro- and/or anti-inflammatory cytokines in elderly breast cancer patients.
J Immunother Cancer
; 3: 45, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26500775
11.
The prognostic impact of specific CD4 T-cell responses is critically dependent on the target antigen in melanoma.
Oncoimmunology
; 4(1): e955683, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26097797
12.
Circulating CD4+ T cells that produce IL4 or IL17 when stimulated by melan-A but not by NY-ESO-1 have negative impacts on survival of patients with stage IV melanoma.
Clin Cancer Res
; 20(16): 4390-9, 2014 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24938524